| Code | 0405B | ||||||||||
| MA number | 15/0199/14-S | ||||||||||
| Product Form: | cps dur 120x140 mg/125 mg/125 mg (fľ.HDPE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | LABORATOIRES JUVISE PHARMACEUTICALS, France | ||||||||||
| Therapeutic Class: | 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | bottle HDPE | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10b fixed combination application |
| MA issued: | 23.06.2014 |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| PIL: |
PIL_Pylera140 mg_125 mg_125 mg cps dur_01.2024.pdf
|
| SPC: |
SPC_Pylera140 mg_125 mg_125 mg cps dur_01.2024.pdf
|
| Safety feature | Yes |
| Data update: | 20.09.2019 |
